The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world evidence of axicabtagene ciloleucel (Axi-cel) for the treatment of large B-cell lymphoma (LBCL) in the United States (US).
 
Caron A. Jacobson
Honoraria - Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Humanigen; Kite/Gilead; Nkarta; Novartis; precision biosciences
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Humanigen; Kite/Gilead; Lonza; Nkarta; Novartis; Precision Biosciences
Speakers' Bureau - Axis Bioservices; Clinical Care Options
Research Funding - Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer
Travel, Accommodations, Expenses - Kite/Gilead; Novartis; Precision Biosciences
 
Frederick Lundry Locke
Consulting or Advisory Role - Alimera Sciences; Amgen; Bluebird Bio; Bristol-Myers Squibb; Calibr; Celgene; Cellular Biomedicine Group; Cowen; EcoR1 Capital; GammaDelta Therapeutics; Gerson Lehrman Group; Iovance Biotherapeutics; Legend Biotech; Novartis; WUGEN, Inc.
Research Funding - Alimera Sciences (Inst); Kite, a Gilead company (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - CAR T Cells with Enhanced Metabolic Fitness. Serial Number: 62/939,727 (Inst); Double Mutant Survivin Vaccine. US010414810B2. (Inst); Evolutionary Dynamics of Non-Hodgkin Lymphoma CAR-T cell therapy. Serial Number: 62/879,534. (Inst); Methods of Enhancing CAR T Cell Therapies. Serial Number: 62/892,292. (Inst)
Travel, Accommodations, Expenses - Kite, a Gilead company
 
Zhen-Huan Hu
No Relationships to Disclose
 
Tanya Siddiqi
Consulting or Advisory Role - AstraZeneca; BeiGene; Bristol-Myers Squibb; Celgene; Juno Therapeutics; Kite, a Gilead Company; Pharmacyclics
Speakers' Bureau - AstraZeneca; Janssen; Pharmacyclics; Research to Practice
Research Funding - Ascentage Pharma (Inst); BeiGene (Inst); Celgene (Inst); Juno Therapeutics (Inst); Kite, a Gilead company (Inst); Oncternal Therapeutics (Inst); TG Therapeutics (Inst)
 
Sairah Ahmed
Consulting or Advisory Role - Tessa Therapeutics
Research Funding - Merck (Inst); Seagen (Inst)
 
Armin Ghobadi
Honoraria - Kite, a Gilead company
Consulting or Advisory Role - Amgen; Celgene; Kite, a Gilead company; WUGEN, Inc.
Speakers' Bureau - Kite, a Gilead company
Research Funding - Amgen; Kite, a Gilead company
 
David Bernard Miklos
Consulting or Advisory Role - Adaptive Biotechnologies; Alimera Sciences; Janssen; Juno/Celgene; Kite, a Gilead company; Miltenyi Biotec; Novartis; Pharmacyclics; Precision Biosciences
Research Funding - Adaptive Biotechnologies; Alimera Sciences; Kite, a Gilead company; Novartis; Novartis; Pharmacyclics; Precision Biosciences; Roche/Genentech
Patents, Royalties, Other Intellectual Property - Patent held with Pharmacyclics supporting Ibrutinib for cGVHD (no royalty claim)
Travel, Accommodations, Expenses - Adaptive Biotechnologies; Juno Therapeutics; Kite, a Gilead company; Miltenyi Biotec; Novartis; Pharmacyclics/Janssen
 
Yi Lin
Consulting or Advisory Role - Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Gamida Cell (Inst); Janssen Oncology (Inst); Juno Therapeutics (Inst); Kite/Gilead (Inst); Legend Biotech (Inst); Novartis (Inst); Sorrento Therapeutics (Inst); Vineti (Inst)
Research Funding - Bluebird Bio (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Merck (Inst); Takeda (Inst)
 
Miguel-Angel Perales
Stock and Other Ownership Interests - NexImmune
Honoraria - MorphoSys
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celgene; Cidara Therapeutics; Incyte; Kite/Gilead; Medigene; Merck; MolMed; Nektar; NexImmune; Novartis; Omeros; Servier/Pfizer; Takeda; Vor Biopharma
Research Funding - Incyte (Inst); Kite, a Gilead company (Inst); Miltenyi Biotec (Inst); Nektar (Inst); Novartis (Inst)
 
Matthew Alexander Lunning
Consulting or Advisory Role - Acrotech Biopharma; ADC Therapeutics; AstraZeneca; BeiGene; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Gilead Sciences; Janssen Oncology; Karyopharm Therapeutics; Kite, a Gilead company; Legend Biotech; MorphoSys; Myeloid Therapeutics; Novartis; Spectrum Pharmaceuticals; TG Therapeutics; Verastem
Research Funding - Celgene (Inst); Celgene (Inst); Celgene (Inst); curis (Inst); Janssen Oncology (Inst); Juno Therapeutics (Inst); Juno Therapeutics (Inst); miRagen (Inst); TG Therapeutics (Inst); TG Therapeutics (Inst)
 
Megan Herr
No Relationships to Disclose
 
Brian T. Hill
Honoraria - Abbvie; AstraZeneca; Bayer; BeiGene; Celgene; Epizyme; Genentech; Gilead Sciences; Karyopharm Therapeutics; MorphoSys; Novartis; Novartis; Pfizer; Pharmacyclics
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Epizyme; Genentech; Gilead Sciences; Karyopharm Therapeutics; MorphoSys; Novartis
Research Funding - Abbvie (Inst); Amgen (Inst); Celgene (Inst); Genentech (Inst); Karyopharm Therapeutics (Inst); Kite/Gilead (Inst); Takeda (Inst); TG Therapeutics (Inst)
 
Siddhartha Ganguly
Honoraria - Astellas Pharma; Kite, a Gilead company; Seagen
Consulting or Advisory Role - Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Sanofi/Aventis
Speakers' Bureau - Kite, a Gilead company; Seagen
Research Funding - Daiichi Sankyo (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Kite, a Gilead company; Seagen
 
Hua Dong
Employment - Kite, a Gilead company
 
Sarah Nikiforow
Consulting or Advisory Role - Iovance Biotherapeutics; Kite/Gilead; NKarta; Novartis
Travel, Accommodations, Expenses - NKarta
 
Jing Xie
Employment - Kite, a Gilead company
 
Hairong Xu
Employment - Kite, a Gilead company
 
Michele Hooper
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - Gilead Sciences
 
Jun Kawashima
Employment - Kite, A Gilead Company
Stock and Other Ownership Interests - Gilead Sciences
 
Marcelo C. Pasquini
Honoraria - Celgene
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Medigene (Inst); Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Kite/Gilead (Inst); Novartis (Inst)